Endoscopic Management of Pancreatic Neoplasms (2nd Edition)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 15 October 2025 | Viewed by 907
Special Issue Editor
2. School Medicine, The University of Adelaide, Adelaide, SA 5005, Australia
Interests: pancreatic cancer; endoscopic ultrasound; personalized medicine; fine needle aspiration; organoids; radiation therapy; fiducial guided therapy; intra-tumoural radioactive implantation; cholangioscopy; pancreatoscopy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The prevalence and incidence of pancreatic cancer are increasing, with it being on track to soon becoming the second most frequent cause of cancer death in the world. Unfortunately, only 15% to 20% of pancreatic cancers are suitable for surgery and a potential cure at diagnosis. Thus, the management of over 80% of patients with pancreatic cancer relies on chemo-radiotherapy, endoscopic treatment, and palliative care.
In the management of pancreatic cancer, the role of endoscopes is expanding from diagnosis to treatment. For example, endoscopic biliary stenting is still a major topic of discussion in malignant biliary obstruction during pancreatic cancer, since recurrent biliary obstruction or stent-related adverse events could create obstacles in the clinical course. In this context, several new approaches for the management of biliary obstruction (e.g., new stents or EUS-guided biliary drainage) are presented.
This Special Issue aims to present up-to-date and recent advances that have been made in the field of endoscopy for pancreatic cancer or neoplasms. More specifically, this Special Issue will cover the following topics:
- Endoscopic ultrasound (EUS) and related techniques in the diagnosis of pancreatic cancer;
- The role of EUS-guided tissue acquisition in the characterization of tumour behaviour and guiding therapy, including biomarker and genomic analyses, as well as creating organoids and xenografts for drug testing;
- EUS-guided radiation therapy, including intra-tumoural radioactive implantation;
- Endoscopic alleviation of biliary and duodenal obstruction due to pancreatic cancer;
- Endoscopic therapy for pancreatic cystic neoplasms;
- The role of EUS-guided techniques to further characterize pancreatic cystic neoplasms;
- Endoscopic therapy for pancreatic neuroendocrine tumours;
- Future endoscopic treatments of pancreatic cancer.
In this Special Issue, we aim to collect evidence of the efficacy and safety of endoscopic procedures, such as cutting-edge approaches, large-scale comparisons, and review articles of specific topics in the management of pancreatic cancer.
We believe that the content of this Special Issue will not only consolidate our current knowledge in the field but also stimulate further innovation and research in endoscopic techniques to deliver targeted therapy. In combination with the advances in systemic chemotherapy, such improvements in endoscopic therapies for pancreatic cancer will result in better outcomes.
Yours faithfully,
Dr. Nam Quoc Nguyen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- pancreatic neoplasm
- endoscopic retrograde cholangiopancreatography
- endoscopic ultrasound
- fine needle aspiration/biopsy
- local treatment
- biliary stent
- biliary drainage
- contrast enhancement
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
